| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PPP1R14A |
PPP1R14A, CPI17, PPP1INL: Protein phosphatase 1 regulatory subunit 14A |
5.505 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
CAV1 |
CAV1, CAV: Caveolin-1 |
5.505 |
Evidence |
|
| PAK4 |
PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| LATS1 |
LATS1, WARTS: Serine/threonine-protein kinase LATS1 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| DAB1 |
DAB1: Disabled homolog 1 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| WASPIP |
IPI00552369 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
5.505 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
PPP1R14A |
PPP1R14A, CPI17, PPP1INL: Protein phosphatase 1 regulatory subunit 14A |
5.505 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
HUWE1 |
HUWE1, KIAA0312, HSPC272, KIAA1578, UREB1: E3 ubiquitin-protein ligase HUWE1 |
5.497 |
Evidence |
|
| ITGB1BP1 |
ITGB1BP1, ICAP1: Integrin beta-1-binding protein 1 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
5.497 |
Evidence |
|
| SGK |
SGK, SGK1: Serine/threonine-protein kinase Sgk1 |
ILK |
ILK, ILK1, ILK2: Integrin-linked protein kinase |
5.497 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
5.495 |
Evidence |
|
| NMT1 |
NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
5.495 |
Evidence |
|
| GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
TIAM1 |
TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 |
5.492 |
Evidence |
|
| EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
5.492 |
Evidence |
|
| GRIA4 |
GRIA4, GLUR4: Glutamate receptor 4 precursor |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
5.492 |
Evidence |
|
| PRKG1 |
PRKG1, PRKG1B, PRKGR1B: cGMP-dependent protein kinase 1, beta isozyme |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
5.492 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
5.49 |
Evidence |
|
| RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
5.49 |
Evidence |
|
| IGFBP5 |
IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
5.485 |
Evidence |
|
| SNCG |
SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
5.485 |
Evidence |
|
| CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
CDK3 |
CDK3: Cell division protein kinase 3 |
5.482 |
Evidence |
|
| RANBP3 |
RANBP3: Ran-binding protein 3 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
5.482 |
Evidence |
|